Phenergan Toxicity Allegedly Causes Cardiac Arrest and Death
Updated on
Case Overview
This case involves a twenty-seven-year-old patient that presented to the emergency department complaining of nausea, diarrhea, and vomiting associated with a severe cough. He was treated with Promethazine, Dilaudid, Zofran, Ultram, Pantoprazole, Fentanyl, and Phenergan. Additionally, he was given a prescription for Phenergan upon discharge from the emergency room. The patient returned to the emergency room two days later with the same complaints. He was treated with Hydromorphone, Prochlorperazine, and Pantoprazole. Once again, he was discharged without an extensive workup to rule out life-threatening cardiac or respiratory disease. Three days after the final discharge, the patient was found dead in his home. Contributing factors to his death included the lethal combination of Phenergan, Hydrocodone, and Diphenhydramine.
About the author
Michael Talve, CEO
Michael Talve stands at the forefront of legal innovation as the CEO and Managing Director of Expert Institute. Under his leadership, the Expert Institute has established itself as a vital player in the legal technology arena, revolutionizing how lawyers connect with world-class experts and access advanced legal technology. Michael's role involves not only steering the company's strategic direction but also ensuring the delivery of unparalleled intelligence and cutting-edge solutions to legal professionals. His work at Expert Institute has been instrumental in enhancing the capabilities of attorneys in case preparation and execution, making a significant impact on the legal industry's approach to expert consultation and technological integration. Michael's vision and execution have positioned the Expert Institute as a key facilitator in the intersection of law and technology.
Subscribe to our newsletter
Join our newsletter to stay up to date on legal news, insights and product updates from Expert Institute.
Sign up nowFind an expert witness near you
What State is your case in?
Subscribe to our newsletter
Join our newsletter to stay up to date on legal news, insights and product updates from Expert Institute.